|
|
||||||||
Eur J Cardiothorac Surg 2001;20:140-146
© 2001 Elsevier Science NL
a Department of Clinical and Experimental Medicine, Division of Cardiac Surgery, University of Catanzaro, Catanzaro, Italy
b Department of Clinical and Experimental Medicine, Division of Cardiology, University of Catanzaro, Catanzaro, Italy
Received 12 October 2000; received in revised form 21 March 2001; accepted 11 April 2001.
Corresponding author. Via S. Giacomo dei Capri 29, 80128 Naples, Italy. Tel.: +39-0961-712309; fax: +39-0961-775337
e-mail: chello{at}unicz.it
Objective: The purpose of this study was to investigate the effectiveness of atrial and brain natriuretic peptides (ANP and BNP, respectively) as indicators of recovery of left ventricular (LV) function after coronary surgery. Methods: We measured the concentrations of these peptides in 31 patients with poor LV function (ejection fraction, EF<35%) undergoing coronary artery bypass, and evaluated their correlation with the echocardiographic indexes of LV function. Results: Pre-operatively, the plasma levels of both ANP and BNP were markedly higher in coronary patients than in normal control subjects, and strongly correlated with both EF (BNP: r=-0.8, P<0.001; ANP: r=-0.6, P<0.001) and wall motion score index (WMSI). At post-operative follow up, plasma levels of both natriuretic peptides were markedly reduced compared with pre-operative values in 21 patients. In addition, the post-operativepre-operative differences of BNP (
BNP) and ANP (
ANP) plasma levels strongly correlated with the differences of both EF (r=-0.7, P<0.0001 vs.
BNP; r=-0.6, P=0.0003 vs.
ANP) and WMSI (r=0.6, P=0.002 vs.
BNP; r=0.6, P=0.04 vs.
ANP). Finally, by logistic regression analysis, BNP appeared a significant predictor of LVEF recovery after surgery. Conclusion: Plasma levels of ANP and BNP might be used in routine clinical practice as a support to echocardiography in detecting recovery of the LV function after coronary surgery.
Key Words: Atrial natriuretic peptides Brain natriuretic peptides Left ventricular dysfunction Coronary bypass
This article has been cited by other articles:
![]() |
U. Sartipy, A. Albage, P. T. Larsson, P. Insulander, and D. Lindblom Changes in B-type natriuretic peptides after surgical ventricular restoration Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 922 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cannesson, C. Bionda, B. Gostoli, O. Raisky, S. di Filippo, D. Bompard, C. Vedrinne, R. Rousson, J. Ninet, J. Neidecker, et al. Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation Anesth. Analg., May 1, 2007; 104(5): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Huang, E.-T. Wu, W.-J. Ko, L.-P. Lai, J. Hsu, C.-I. Chang, I.-S. Chiu, S.-S. Wang, M.-H. Wu, F.-Y. Lin, et al. Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support Ann. Thorac. Surg., June 1, 2006; 81(6): 2267 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reyes, G. Fores, R. Hugo Rodriguez-Abella, G. Cuerpo, J. L. Vallejo, C. Romero, and A. Pinto NT-proBNP in cardiac surgery: a new tool for the management of our patients? Interactive CardioVascular and Thoracic Surgery, June 1, 2005; 4(3): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia, K. Julier, L. Bestmann, A. Zollinger, L. K. von Segesser, T. Pasch, D. R. Spahn, and M. Zaugg Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery Br. J. Anaesth., February 1, 2005; 94(2): 159 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schenk, P. M. McCarthy, R. C. Starling, K. J. Hoercher, M. D. Hail, Y. Ootaki, G. S. Francis, K. Doi, J. B. Young, and K. Fukamachi Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 38 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Georges, F. Forestier, N. Valli, A. Plogin, G. Janvier, and L. Bordenave Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 941 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hutfless, R. Kazanegra, M. Madani, M. A. Bhalla, A. Tulua-Tata, A. Chen, P. Clopton, C. James, A. Chiu, and A. S. Maisel Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1873 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Song, Y. Kobayashi, and H. Michi Clinical Implication of Atrial and Brain Natriuretic Peptide in Coronary Artery Bypass Grafting Asian Cardiovasc Thorac Ann, March 1, 2004; 12(1): 41 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Berendes, C. Schmidt, H. Van Aken, M. G. Hartlage, M. Rothenburger, S. Wirtz, H. H. Scheld, G. Brodner, and M. Walter A-Type and B-Type Natriuretic Peptides in Cardiac Surgical Procedures Anesth. Analg., January 1, 2004; 98(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |